Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-2 study): a plain language summary

Strober B, Thaçi D, Sofen H, Kircik L, Gordon KB, Foley P, Rich P, Paul C, Bagel J, Colston E, Throup J, Kundu S, Sekaran C, Linaberry M, Banerjee S, Papp KA. Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-2 study): a plain language summary. Immunotherapy. 2023 May 7. doi: 10.2217/imt-2023-0062. Epub ahead of print. PMID: 37150956.


Related Posts